MiR-34a regulates mouse neural stem cell differentiation

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  AranhaMá, Márcia M ^a   Santos, Daniela M ^a   Solá, Susana ^a   Steer, Clifford J ^b   RodriguesCecí, Cecília M P ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MICRORNA; MICRORNA 34; PROTEIN P53; SIRTUIN 1; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL ELONGATION; CONTROLLED STUDY; DOWN REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC REGULATION; MITOSIS INDEX; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE FIBER GROWTH; NEURAL STEM CELL; NONHUMAN; PROTEIN DNA BINDING;

EID: 79961058496     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021396     Document Type: Article

References (63)

1. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Shivdasani RA, (2006) MicroRNAs: regulators of gene expression and cell differentiation. Blood 108: 3646-3653.
3. Krol J, Loedige I, Filipowicz W, (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11: 597-610.
4. Murchison EP, Partridge JF, Tam OH, Cheloufi S, Hannon GJ, (2005) Characterization of Dicer-deficient murine embryonic stem cells. Proc Natl Acad Sci USA 102: 12135-12140.
5. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, et al. (2003) Dicer is essential for mouse development. Nat Genet 35: 215-217.
6. Hermeking H, (2010) The miR-34 family in cancer and apoptosis. Cell Death Differ 17: 193-199.
7. Lodygin D, Tarasov V, Epanchintsev A, Berking C, Knyazeva T, et al. (2008) Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7: 2591-2600.
8. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, et al. (2007) p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17: 1298-1307.
9. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, et al. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26: 745-752.
10. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY, (2007) MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 67: 8433-8438.
11. He L, He X, Lim LP, de Stanchina E, Xuan Z, et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134.
12. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, et al. (2007) Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26: 731-743.
13. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, et al. (2007) Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6: 1586-1593.
14. Hashimi ST, Fulcher JA, Chang MH, Gov L, Wang S, et al. (2009) MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation. Blood 114: 404-414.
15. Ichimura A, Ruike Y, Terasawa K, Shimizu K, Tsujimoto G, (2010) MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells. Mol Pharmacol 77: 1016-1024.
16. Navarro F, Gutman D, Meire E, Caceres M, Rigoutsos I, et al. (2009) miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood 114: 2181-2192.
17. Tarantino C, Paolella G, Cozzuto L, Minopoli G, Pastore L, et al. (2010) miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells. FASEB J 24: 3255-3263.
18. Blander G, Guarente L, (2004) The Sir2 family of protein deacetylases. Annu Rev Biochem 73: 417-435.
19. Finkel T, Deng CX, Mostoslavsky R, (2009) Recent progress in the biology and physiology of sirtuins. Nature 460: 587-591.
20. Haigis MC, Guarente LP, (2006) Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev 20: 2913-2921.
21. Mantel C, Broxmeyer HE, (2008) Sirtuin 1, stem cells, aging, and stem cell aging. Curr Opin Hematol 15: 326-331.
22. Guarente L, Picard F, (2005) Calorie restriction-the SIR2 connection. Cell 120: 473-482.
23. Wang RH, Sengupta K, Li C, Kim HS, Cao L, et al. (2008) Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 14: 312-323.
24. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, et al. (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-2015.
25. Fulco M, Schiltz RL, Iezzi S, King MT, Zhao P, et al. (2003) Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol Cell 12: 51-62.
26. Blander G, Bhimavarapu A, Mammone T, Maes D, Elliston K, et al. (2009) SIRT1 promotes differentiation of normal human keratinocytes. J Invest Dermatol 129: 41-49.
27. Ou X, Chae HD, Wang RH, Shelley WC, Cooper S, et al. (2010) SIRT1 deficiency compromises mouse embryonic stem cell hematopoietic differentiation, and embryonic and adult hematopoiesis in the mouse. Blood 117: 440-450.
28. Hisahara S, Chiba S, Matsumoto H, Tanno M, Yagi H, et al. (2008) Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocation. Proc Natl Acad Sci USA 105: 15599-15604.
29. Prozorovski T, Schulze-Topphoff U, Glumm R, Baumgart J, Schroter F, et al. (2008) Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nat Cell Biol 10: 385-394.
30. Aranha MM, Solá S, Low WC, Steer CJ, Rodrigues CM, (2009) Caspases and p53 modulate FOXO3A/Id1 signaling during mouse neural stem cell differentiation. J Cell Biochem 107: 748-758.
31. Aranha MM, Santos DM, Xavier JM, Low WC, Steer CJ, et al. (2010) Apoptosis-associated microRNAs are modulated in mouse, rat and human neural differentiation. BMC Genomics 11: 514.
32. Calvanese V, Lara E, Suarez-Alvarez B, Abu Dawud R, Vazquez-Chantada M, et al. (2010) Sirtuin 1 regulation of developmental genes during differentiation of stem cells. Proc Natl Acad Sci USA 107: 13736-13741.
33. Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, et al. (2002) Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J 21: 2383-2396.
34. Wang Y, Schwedes JF, Parks D, Mann K, Tegtmeyer P, (1995) Interaction of p53 with its consensus DNA-binding site. Mol Cell Biol 15: 2157-2165.
35. Wei JS, Song YK, Durinck S, Chen QR, Cheuk AT, et al. (2008) The MYCN oncogene is a direct target of miR-34a. Oncogene 27: 5204-5213.
36. Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, et al. (2009) MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res 69: 7569-7576.
37. He X, He L, Hannon GJ, (2007) The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res 67: 11099-11101.
38. Luo J, Nikolaev AY, Imai S, Chen D, Su F, et al. (2001) Negative control of p53 by Sir2α promotes cell survival under stress. Cell 107: 137-148.
39. Vaziri H, Dessain SK, Eaton ENg, Imai SI, Frye RA, et al. (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159.
40. Barlev NA, Liu L, Chehab NH, Mansfield K, Harris KG, et al. (2001) Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell 8: 1243-1254.
41. Di Giovanni S, Knights CD, Rao M, Yakovlev A, Beers J, et al. (2006) The tumor suppressor protein p53 is required for neurite outgrowth and axonal regeneration. EMBO J 25: 4084-4096.
42. Han MK, Song EK, Guo Y, Ou X, Mantel C, et al. (2008) SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2: 241-251.
43. Armesilla-Diaz A, Bragado P, Del Valle I, Cuevas E, Lazaro I, et al. (2009) p53 regulates the self-renewal and differentiation of neural precursors. Neuroscience 158: 1378-1389.
44. Gil-Perotin S, Marin-Husstege M, Li J, Soriano-Navarro M, Zindy F, et al. (2006) Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors. J Neurosci 26: 1107-1116.
45. Qin H, Yu T, Qing T, Liu Y, Zhao Y, et al. (2007) Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J Biol Chem 282: 5842-5852.
46. Zhang J, Yan W, Chen X, (2006) p53 is required for nerve growth factor-mediated differentiation of PC12 cells via regulation of TrkA levels. Cell Death Differ 13: 2118-2128.
47. Brynczka C, Labhart P, Merrick BA, (2007) NGF-mediated transcriptional targets of p53 in PC12 neuronal differentiation. BMC Genomics 8: 139.
48. Brenner JL, Jasiewicz KL, Fahley AF, Kemp BJ, Abbott AL, (2010) Loss of individual microRNAs causes mutant phenotypes in sensitized genetic backgrounds in C. elegans. Curr Biol 20: 1321-1325.
49. Shukla Y, Singh R, (2011) Resveratrol and cellular mechanisms of cancer prevention. Ann NY Acad Sci 1215: 1-8.
50. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.
51. Brakenhielm E, Cao R, Cao Y, (2001) Suppression of angiogenesis, tumor growth, andwound healing by resveratrol, a natural compound in red wine and grapes. FASEB J 15: 1798-1800.
52. Agarwal C, Sharma Y, Agarwal R, (2000) Anticarcinogenic effect of a polyphenolic fraction isolated from grape seeds in human prostate carcinoma DU145 cells: Modulation of mitogenic signaling and cell-cycle regulators and induction of G1 arrest and apoptosis. Mol Carcinog 28: 129-138.
53. Wung BS, Hsu MC, Wu CC, Hsieh CW, (2005) Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation. Life Sci 78: 389-397.
54. Csiszar A, Smith K, Labinskyy N, Orosz Z, Rivera A, et al. (2006) Resveratrol attenuates TNF-α-induced activation of coronary arterial endothelial cells: role of NF-κB inhibition. Am J Physiol 291: H1694-H1699.
55. Pezzuto JM, (2006) Resveratrol as a cancer chemopreventive agent. In: Aggarwal BB, Shishodia S, editors. Resveratrol in Health and Disease New York, New York Marcel Dekker, Inc pp. 233-383.
56. Reynolds BA, Weiss S, (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255: 1707-1710.
57. Reynolds BA, Weiss S, (1996) Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 175: 1-13.
58. Rietze R, Reynolds B, (2006) Neural stem cell isolation and characterization. Methods Enzymol 419: 3-23.
59. Romero-Calvo I, Ocon B, Martinez-Moya P, Suarez MD, Zarzuelo A, et al. (2010) Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem 401: 318-320.
60. Mijering E, Jacob M, Sarria JC, Steiner P, Hirling H, et al. (2004) Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry A 58: 167-176.
61. Schreiber E, Matthias P, Muller MM, Schaffner W, (1989) Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17: 6419.
62. Milagre I, Nunes MJ, Gama MJ, Silva RF, Pascussi JM, et al. (2008) Transcriptional regulation of the human CYP46A1 brain-specific expression by Sp transcription factors. J Neurochem 106: 835-849.
63. Schutte B, Nuydens R, Geerts H, Ramaekers F, (1998) Annexin V binding assay as a tool to measure apoptosis in differentiated neuronal cells. J Neurosci Methods 86: 63-69.